OSTEOPOROSIS IN LYSINURIC PROTEIN INTOLERANCE

被引:31
作者
PARTO, K
PENTTINEN, R
PARONEN, I
PELLINIEMI, L
SIMELL, O
机构
[1] UNIV TAMPERE, DEPT PATHOL, SF-33520 TAMPERE, FINLAND
[2] UNIV TURKU, ELECTRON MICROSCOPY LAB, SF-20520 TURKU 52, FINLAND
[3] UNIV TURKU, CENT HOSP, DEPT MED BIOCHEM, SF-20520 TURKU 52, FINLAND
关键词
D O I
10.1007/BF00710296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lysinuric protein intolerance (LPI) is an autosomal recessive disease characterized by defective transport of cationic amino acids. Patients have an increased incidence of fractures and their skeletal radiographs show osteoporosis. The aim of the study was to characterize the osteopenia in LPI. Twenty-nine Finnish LPI patients (age range 3.7-44.4 years) were screened for parameters of bone metabolism. Morphometric analysis of bone was carried out in specimens of 9 patients. Collagen synthesis was studied with cultured skin fibroblasts (4 patients) and collagen fibril sizes (3 patients) were measured using electron microscopy. Most histological bone specimens (8/9) showed osteoporosis. Osteomalacia was excluded. Routine clinical laboratory tests were unrevealing. The concentrations of free hydroxyproline and type Ill procollagen N-propeptide in serum and the urinary excretion of hydroxyproline were increased in almost all patients during their growth and in about half of adult patients. Collagen synthesis in LPI fibroblast cultures was significantly decreased compared with that in age-matched controls at 5 (p < 0.01), 14 (p < 0.01) and still at 30 years (p < 0.01), whereas no difference was observed at the age of 44 years (p = N.S.). Osteoporosis in LPI might reflect defective matrix protein synthesis caused by protein deprivation and deficiency of cationic amino acids. Increased collagen turnover can also contribute to the osteoporosis.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 35 条
[1]   SPLANCHNIC AND RENAL EXTRACTION OF CIRCULATING TYPE-III PROCOLLAGEN AMINOTERMINAL PROPEPTIDE IN PATIENTS WITH NORMAL LIVER-FUNCTION AND IN PATIENTS WITH ALCOHOLIC CIRRHOSIS [J].
BENTSEN, KD ;
HENRIKSEN, JH ;
BENDTSEN, F ;
HORSLEVPETERSEN, K ;
LORENZEN, I .
HEPATOLOGY, 1990, 11 (06) :957-963
[2]  
BOSKEY AL, 1990, ORTHOP CLIN N AM, V21, P19
[3]  
BRODY LC, 1992, J BIOL CHEM, V267, P3302
[4]  
CARPENTER TO, 1985, NEW ENGL J MED, V31, P290
[5]   INSITU DETECTION OF MYCOPLASMA CONTAMINATION IN CELL-CULTURES BY FLUORESCENT HOECHST-33258 STAIN [J].
CHEN, TR .
EXPERIMENTAL CELL RESEARCH, 1977, 104 (02) :255-262
[6]  
CHRISTIANSEN C, 1991, AM J MED, V90, P107
[7]   SERUM AND URINARY MARKERS OF BONE REMODELING - ASSESSMENT OF BONE TURNOVER [J].
EPSTEIN, S .
ENDOCRINE REVIEWS, 1988, 9 (04) :437-449
[8]   FEEDBACK-REGULATION OF COLLAGEN GENE-EXPRESSION - A TROJAN HORSE APPROACH [J].
FOUSER, L ;
SAGE, EH ;
CLARK, J ;
BORNSTEIN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10158-10162
[9]   CLINICAL MEASUREMENT OF URINARY TOTAL HYDROXYPROLINE EXCRETION [J].
GASSER, A ;
CELADA, A ;
COURVOISIER, B ;
DEPIERRE, D ;
HULME, PM ;
RINSLER, M ;
WILLIAMS, D ;
WOOTTON, R .
CLINICA CHIMICA ACTA, 1979, 95 (03) :487-491
[10]  
GEVERS G, 1987, COLLAGEN REL RES, V7, P435